M. Andreoletti

1.3k total citations · 1 hit paper
8 papers, 844 citations indexed

About

M. Andreoletti is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, M. Andreoletti has authored 8 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 4 papers in Epidemiology and 1 paper in Infectious Diseases. Recurrent topics in M. Andreoletti's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis B Virus Studies (3 papers). M. Andreoletti is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis B Virus Studies (3 papers). M. Andreoletti collaborates with scholars based in Italy and Poland. M. Andreoletti's co-authors include Agostino Colli, Anna Ludovica Fracanzani, Ester Vanni, Luca Valenti, Daniela Bignamini, Silvia Fargion, Giulio Marchesini, Elisabetta Bugianesi, E. Fatta and C. Bertelli and has published in prestigious journals such as Hepatology, Radiology and Journal of Hepatology.

In The Last Decade

M. Andreoletti

7 papers receiving 817 citations

Hit Papers

Risk of severe liver disease in nonalcoholic fatty liver ... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Andreoletti Italy 5 762 419 293 123 111 8 844
Vincent Thibault France 4 757 1.0× 334 0.8× 338 1.2× 163 1.3× 166 1.5× 9 849
Flavia Mendes United States 13 641 0.8× 479 1.1× 218 0.7× 205 1.7× 67 0.6× 19 806
William Haufe United States 11 936 1.2× 553 1.3× 301 1.0× 113 0.9× 45 0.4× 14 1.0k
Sam Trinh United States 7 629 0.8× 279 0.7× 270 0.9× 58 0.5× 140 1.3× 12 693
Peter Eddowes United Kingdom 6 1.1k 1.4× 686 1.6× 302 1.0× 195 1.6× 78 0.7× 14 1.2k
Osman Özdoğan Türkiye 16 803 1.1× 504 1.2× 168 0.6× 235 1.9× 82 0.7× 66 1.1k
S. Francioso Italy 12 486 0.6× 245 0.6× 245 0.8× 104 0.8× 106 1.0× 24 621
Pierre M. Gholam United States 8 376 0.5× 200 0.5× 177 0.6× 101 0.8× 104 0.9× 22 505
Javier Lizardi-Cervera Mexico 8 440 0.6× 183 0.4× 235 0.8× 151 1.2× 86 0.8× 22 517
Mayada Metwally Australia 4 817 1.1× 412 1.0× 334 1.1× 99 0.8× 150 1.4× 6 883

Countries citing papers authored by M. Andreoletti

Since Specialization
Citations

This map shows the geographic impact of M. Andreoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Andreoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Andreoletti more than expected).

Fields of papers citing papers by M. Andreoletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Andreoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Andreoletti. The network helps show where M. Andreoletti may publish in the future.

Co-authorship network of co-authors of M. Andreoletti

This figure shows the co-authorship network connecting the top 25 collaborators of M. Andreoletti. A scholar is included among the top collaborators of M. Andreoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Andreoletti. M. Andreoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Borroni, G., M. Cazzaniga, M. Andreoletti, et al.. (2012). Low glomerular filtration rate is a risk factor for ribavirin‐associated anaemia in old patients with chronic hepatitis C. Journal of Viral Hepatitis. 20(4). e90–5. 6 indexed citations
3.
Spreafico, Marta, Barbara Foglieni, L. Raffaele, et al.. (2010). 664 ACUTE B HEPATITIS AFTER TRANSFUSION OF RED BLOOD CELLS FROM A DONOR WITH OCCULT HEPATITIS B VIRUS INFECTION. Journal of Hepatology. 52. S259–S259.
4.
Terreni, N., M. Andreoletti, G. Borroni, et al.. (2009). RETROSPECTIVE ANALYSIS OF THE EFFICACY OF PEG-IFN ALFA-2B VS PEG-IFN ALFA-2A PLUS RIBAVIRIN IN TREATMENT NAÏVE CHRONIC HCV PATIENTS. Digestive and Liver Disease. 41. S113–S113. 1 indexed citations
5.
Borroni, G., M. Andreoletti, Roberto Ceriani, et al.. (2008). Effectiveness of pegylated interferon/ribavirin combination in ‘real world’ patients with chronic hepatitis C virus infection. Alimentary Pharmacology & Therapeutics. 27(9). 790–797. 35 indexed citations
6.
Fracanzani, Anna Ludovica, Luca Valenti, Elisabetta Bugianesi, et al.. (2008). Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology. 48(3). 792–798. 530 indexed citations breakdown →
7.
Colli, Agostino, et al.. (2003). Severe Liver Fibrosis or Cirrhosis: Accuracy of US for Detection—Analysis of 300 Cases. Radiology. 227(1). 89–94. 245 indexed citations
8.
Zuccato, Ettore, M. Andreoletti, F. Marcucci, et al.. (1983). Respiratory excretion of hydrogen and methane in Italian subjects after ingestion of lactose and milk. European Journal of Clinical Investigation. 13(3). 261–266. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026